Among the acquired products are 2 oral vaccines to help in the prevention of travel-related bacterial infections: Vaxchora® (Cholera vaccine, Live, Oral) for the prevention of cholera and Vivotif ...

What are the emerging trends in the Vaxchora market? Yielding to the pressing demands of cholera prevention in endemic and high-risk areas, expanded regional vaccine approvals have surfaced as a ...

and cholera vaccine Vaxchora pushed the company’s travel health Q3 business revenue up 21% compared to last year. Bavarian Nordic could be adding a new vaccine to its immunisation rosters next ...

The positive opinion for Rybelsus came alongside CHMP backing for Alnylam's rare disease drug Givlaari, as well as an oral cholera vaccine – Vaxchora – developed by Emergent Biosolutions and ...

The firm’s products include ACAM2000, BioThrax, Raxibacuma, Vaxchora, and VIGIV. Its business units include Vaccines and Anti-Infectives; Antibody Therapeutics; Devices; and Contract Development ...